These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15924333)

  • 1. Antipsychotics and diabetes: is there an association?
    Mamdani M
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):403-5. PubMed ID: 15924333
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
    Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
    Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy.
    Gianfrancesco F; Wang RH; Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):9-17. PubMed ID: 16517448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
    McIntyre RS; Jerrell JM
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus development conference on antipsychotic drugs and obesity and diabetes.
    ; ; ;
    Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231
    [No Abstract]   [Full Text] [Related]  

  • 6. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
    Silvestre JS; Prous J
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study focuses in on potential cause of antipsychotic-induced diabetes.
    O'Neill MF
    Drug News Perspect; 2005 Oct; 18(8):481-2. PubMed ID: 16391716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific standards: critical comments on the pharmacoepidemiological study of second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia.
    Cohen D
    J Clin Psychopharmacol; 2008 Aug; 28(4):461-2; author reply 462-4. PubMed ID: 18626279
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotics and diabetes: case reports and cohort studies.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):59-71. PubMed ID: 19667653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes in treatment with antipsychotic drugs: who is at risk]].
    Deuschle M
    MMW Fortschr Med; 2005 Dec; 147(51-52):34. PubMed ID: 16402705
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
    Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset type-2 diabetes associated with atypical antipsychotic medications.
    Lambert MT; Copeland LA; Sampson N; Duffy SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):919-23. PubMed ID: 16581171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
    Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
    Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States.
    Buse JB; Cavazzoni P; Hornbuckle K; Hutchins D; Breier A; Jovanovic L
    J Clin Epidemiol; 2003 Feb; 56(2):164-70. PubMed ID: 12654411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research profile. Anti-psychotic drugs. Can they cause type 2? Paul E. Keck, Jr., MD.
    Kordella T
    Diabetes Forecast; 2004 Dec; 57(12):65-7. PubMed ID: 15619762
    [No Abstract]   [Full Text] [Related]  

  • 16. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users.
    Morrato EH; Druss BG; Hartung DM; Valuck RJ; Thomas D; Allen R; Campagna E; Newcomer JW
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):66-75. PubMed ID: 21182154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warning.
    Friedman JH
    Neurology; 2006 Aug; 67(4):564-6. PubMed ID: 16924004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics, elderly patients, and mortality risk.
    Citrome L
    South Med J; 2007 Oct; 100(10):964-5. PubMed ID: 17943033
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood glucose in chronic schizophrenic patients treated with antipsychotics].
    Wetterling T; Schneider B; Weber B
    Psychiatr Prax; 2007 Mar; 34(2):76-80. PubMed ID: 17160751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.